Reduction of anion exchanger 2 expression induces apoptosis of human hepatocellular carcinoma cells

详细信息    查看全文

• 作者：Jin-Ming Hwang ; Shao-Hsuan Kao ; Yi-Hsien Hsieh ; Kuen-Lin Li ; Pei-Hsi Wang ; Li-Song Hsu and Jer-Yuh Liu
• 关键词：Hepatocellular carcinoma ; Anion exchanger 2 ; Antisense oligonucleotide
• 刊名：Molecular and Cellular Biochemistry
• 出版年：2009
• 出版时间：July, 2009
• 年：2009
• 卷：327
• 期：1-2
• 页码：135-144
• 全文大小：551.6 KB

文摘

Anion exchanger (AE) 2, belonging to the chloride–bicarbonate transporter family, has been reported to involve cell survival for hepatocellular carcinoma (HCC) cells. Our previous findings showed that AE2 gene was highly expressed in a poorly differentiated HCC cell line, HA22T/VGH. Additionally, treatment with 4,4′-diisothiocyanatostilbene-2,20-disulfonic acid (DIDS), an AE-specific inhibitor, significantly inhibited cell proliferation and induced cell apoptosis for the HA22T/VGH. To further investigate the biological functions of AE2 in human HCC, suppression of AE2 expression by the antisense oligonucleotide-AE2 (AS-AE2) was performed, and the cell viability, cell cycle regulation, and cell apoptosis for HCC cell lines were monitored. The results showed that AS-AE2 treatment could efficiently suppress the mRNA expression of AE2 for various differentiated HCC cells, including HA22T/VGH, SK-Hep-1, PLC/PRF/5, Hep3B, and HepG2. Moreover, AS-AE2 treatment significantly reduced cell viability, arrested cell cycle at sub-G1 phase, and induced cell apoptosis for the poorly differentiated HA22T/VGH, but not for other moderately or well-differentiated HCC cell lines. The findings indicated that AE2 may play an important role in the progression of HCC cells, and provide a new strategy for the development of therapeutic treatment against human HCC.